Business Standard | Gujarat pharma firms vie for share in cancer drug space Business Standard Ahmedabad-based Intas Pharmaceuticals had launched a biosimilar version of Rituximab called Mabtas in April this year that is used in treating diseases like leukemia and rheumatoid arthritis. A senior company official said on grounds of anonymity that ... |
